US › Healthcare

Milestone Scientific (MLSS)

US · Healthcare · Medical Instruments & Supplies

$0.42+6.07%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.8M

Revenue YoY

+22.3%

Net profit

$-1.1M

EPS

$-0.01

EPS estimate

$-0.01

Net margin

-37.3%

EPS came in at -0.01 against a street estimate of -0.01 — a beat of 0.0%.

Key statistics

Market cap

$36.2M

Forward P/E

18.2

P/B

10.45

Book value

$0.04

EPS (TTM)

$-0.05

52-week high

$0.60

52-week low

$0.22

50-day MA

$0.45

200-day MA

$0.35

Beta

1.07

Analyst view

Analysts rate Milestone Scientific a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $1.25.

Shareholding

Insiders

16.01%

Institutions

5.30%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Milestone Scientific — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.